Skip to main content

Advertisement

SpringerLink
Log in

Olfactomedin 4 expression and functions in innate immunity, inflammation, and cancer

  • NON-THEMATIC REVIEW
  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

Abstract

Olfactomedin 4 (OLFM4) is an olfactomedin domain-containing glycoprotein. Multiple signaling pathways and factors, including NF-κB, Wnt, Notch, PU.1, retinoic acids, estrogen receptor, and miR-486, regulate its expression. OLFM4 interacts with several other proteins, such as gene associated with retinoic-interferon-induced mortality 19 (GRIM-19), cadherins, lectins, nucleotide oligomerization domain-1 (NOD1) and nucleotide oligomerization domain-2 (NOD2), and cathepsins C and D, known to regulate important cellular functions. Recent investigations using Olfm4-deficient mouse models have provided important clues about its in vivo biological functions. Olfm4 inhibited Helicobacter pylori-induced NF-κB pathway activity and inflammation and facilitated H. pylori colonization in the mouse stomach. Olfm4-deficient mice exhibited enhanced immunity against Escherichia coli and Staphylococcus aureus infection. Olfm4 deletion in a chronic granulomatous disease mouse model rescued them from S. aureus infection. Olfm4 deletion in mice treated with azoxymethane/dextran sodium sulfate led to robust intestinal inflammation and intestinal crypt hyperplasia. Olfm4 deletion in Apc Min/+ mice promoted intestinal polyp formation as well as adenocarcinoma development in the distal colon. Further, Olfm4-deficient mice spontaneously developed prostatic epithelial lesions as they age. OLFM4 expression is correlated with cancer differentiation, stage, metastasis, and prognosis in a variety of cancers, suggesting its potential clinical value as an early-stage cancer marker or a therapeutic target. Collectively, these data suggest that OLFM4 plays important roles in innate immunity against bacterial infection, gastrointestinal inflammation, and cancer. In this review, we have summarized OLFM4’s initial characterization, expression, regulation, protein interactions, and biological functions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Snyder, D. A., Rivers, A. M., Yokoe, H., Menco, B. P., & Anholt, R. R. (1991). Olfactomedin: purification, characterization, and localization of a novel olfactory glycoprotein. Biochemistry, 30(38), 9143–9153.

    Article  CAS  PubMed  Google Scholar 

  2. Zeng, L. C., Han, Z. G., & Ma, W. J. (2005). Elucidation of subfamily segregation and intramolecular coevolution of the olfactomedin-like proteins by comprehensive phylogenetic analysis and gene expression pattern assessment. FEBS Letters, 579(25), 5443–5453.

    Article  CAS  PubMed  Google Scholar 

  3. Tomarev, S. I., & Nakaya, N. (2009). Olfactomedin domain-containing proteins: possible mechanisms of action and Functions in normal development and pathology. Molecular Neurobiology, 40(2), 122–138.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Barembaum, M., Moreno, T. A., LaBonne, C., Sechrist, J., & Bronner-Fraser, M. (2000). Noelin-1 is a secreted glycoprotein involved in generation of the neural crest. Nature Cell Biology, 2(4), 219–225.

    Article  CAS  PubMed  Google Scholar 

  5. Moreno, T. A., & Bronner-Fraser, M. (2001). The secreted glycoprotein Noelin-1 promotes neurogenesis in Xenopus. Developmental Biology, 240(2), 340–360.

    Article  CAS  PubMed  Google Scholar 

  6. Stone, E. M., Fingert, J. H., Alward, W. L., Nguyen, T. D., Polansky, J. R., Sunden, S. L., et al. (1997). Identification of a gene that causes primary open angle glaucoma. Science, 275(5300), 668–670.

    Article  CAS  PubMed  Google Scholar 

  7. Adam, M. F., Belmouden, A., Binisti, P., Brezin, A. P., Valtot, F., Bechetoille, A., et al. (1997). Recurrent mutations in a single exon encoding the evolutionarily conserved olfactomedin-homology domain of TIGR in familial open-angle glaucoma. Human Molecular Genetics, 6(12), 2091–2097.

    Article  CAS  PubMed  Google Scholar 

  8. Inomata, H., Haraguchi, T., & Sasai, Y. (2008). Robust stability of the embryonic axial pattern requires a secreted scaffold for chordin degradation. Cell, 134(5), 854–865.

    Article  CAS  PubMed  Google Scholar 

  9. Anholt, R. R. (2014). Olfactomedin proteins: central players in development and disease. Front Cell and Developmental Biology, 2, 6. doi:10.3389/fcell.2014.00006.

    Article  Google Scholar 

  10. Zhang, J., Liu, W. L., Tang, D. C., Chen, L., Wang, M., Pack, S. D., et al. (2002). Identification and characterization of a novel member of olfactomedin-related protein family, hGC-1, expressed during myeloid lineage development. Gene, 283(1–2), 83–93.

    Article  CAS  PubMed  Google Scholar 

  11. Liu, W., Chen, L., Zhu, J., & Rodgers, G. P. (2006). The glycoprotein hGC-1 binds to cadherin and lectins. Experimental Cell Research, 312(10), 1785–1797.

    Article  CAS  PubMed  Google Scholar 

  12. Liu, W., Liu, Y., Zhu, J., Wright, E., Ding, I., & Rodgers, G. P. (2008). Reduced hGC-1 protein expression is associated with malignant progression of colon carcinoma. Clinical Cancer Research, 14(4), 1041–1049.

    Article  CAS  PubMed  Google Scholar 

  13. Liu, W., Zhu, J., Cao, L., & Rodgers, G. P. (2007). Expression of hGC-1 is correlated with differentiation of gastric carcinoma. Histopathology, 51(2), 157–165.

    Article  CAS  PubMed  Google Scholar 

  14. Liu, W., Yan, M., Liu, Y., McLeish, K. R., Coleman, W. G., Jr., & Rodgers, G. P. (2012). Olfactomedin 4 inhibits cathepsin C-mediated protease activities, thereby modulating neutrophil killing of staphylococcus aureus and escherichia coli in mice. Journal of Immunology, 189(5), 2460–2467.

    Article  CAS  Google Scholar 

  15. Liu, W., Yan, M., Sugui, J. A., Li, H., Xu, C., Joo, J., et al. (2013). Olfm4 deletion enhances defense against Staphylococcus aureus in chronic granulomatous disease. The Journal of Clinical Investigation, 123(9), 3751–3755.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Liu, W., Lee, H. W., Liu, Y., Wang, R., & Rodgers, G. P. (2010). Olfactomedin 4 is a novel target gene of retinoic acids and 5-aza-2'-deoxycytidine involved in human myeloid leukemia cell growth, differentiation, and apoptosis. Blood, 116(23), 4938–4947.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Zhang, X., Huang, Q., Yang, Z., Li, Y., & Li, C. Y. (2004). GW112, a novel antiapoptotic protein that promotes tumor growth. Cancer Research, 64(7), 2474–2481.

    Article  CAS  PubMed  Google Scholar 

  18. Clemmensen, S. N., Bohr, C. T., Rorvig, S., Glenthoj, A., Mora-Jensen, H., Cramer, E. P., et al. (2012). Olfactomedin 4 defines a subset of human neutrophils. Journal of Leukocyte Biology, 91(3), 495–500.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Grover, P. K., Hardingham, J. E., & Cummins, A. G. (2010). Stem cell marker olfactomedin 4: critical appraisal of its characteristics and role in tumorigenesis. Cancer Metastasis Reviews, 29(4), 761–775.

    Article  CAS  PubMed  Google Scholar 

  20. Chen, L., Li, H., Liu, W., Zhu, J., Zhao, X., Wright, E., et al. (2011). Olfactomedin 4 suppresses prostate cancer cell growth and metastasis via negative interaction with cathepsin D and SDF-1. Carcinogenesis, 32(7), 986–994.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Rosenbauer, F., Wagner, K., Zhang, P., Knobeloch, K. P., Iwama, A., & Tenen, D. G. (2004). pDP4, a novel glycoprotein secreted by mature granulocytes, is regulated by transcription factor PU.1. Blood, 103(11), 4294–4301.

    Article  CAS  PubMed  Google Scholar 

  22. Dassen, H., Punyadeera, C., Delvoux, B., Schulkens, I., Marchetti, C., Kamps, R., et al. (2010). Olfactomedin-4 regulation by estrogen in the human endometrium requires epidermal growth factor signaling. The American Journal of Pathology, 177(5), 2495–2508.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Oh, H. K., Tan, A. L., Das, K., Ooi, C. H., Deng, N. T., Tan, I. B., et al. (2011). Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer. Clinical Cancer Research, 17(9), 2657–2667.

    Article  CAS  PubMed  Google Scholar 

  24. Ma, H., Tian, T., Liang, S., Liu, X., Shen, H., Xia, M., et al. (2016). Estrogen receptor-mediated miR-486-5p regulation of OLFM4 expression in ovarian cancer. Oncotarget, doi:10.18632/oncotarget.7236.

  25. Chin, K. L., Aerbajinai, W., Zhu, J., Drew, L., Chen, L., Liu, W., et al. (2008). The regulation of OLFM4 expression in myeloid precursor cells relies on NF-kappaB transcription factor. British Journal of Haematology, 143(3), 421–432.

    Article  CAS  PubMed  Google Scholar 

  26. Liu, W., Yan, M., Liu, Y., Wang, R., Li, C., Deng, C., et al. (2010). Olfactomedin 4 down-regulates innate immunity against Helicobacter pylori infection. Proceedings of the National Academy of Sciences of the United States of America, 107(24), 11056–11061.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Kim, K. K., Park, K. S., Song, S. B., & Kim, K. E. (2010). Up regulation of GW112 gene by NF kappaB promotes an antiapoptotic property in gastric cancer cells. Molecular Carcinogenesis, 49(3), 259–270.

    Article  CAS  PubMed  Google Scholar 

  28. Liu, W., Li, H., Hong, S. H., Piszczek, G. P., Chen, W., & Rodgers, G. P. (2016). Olfactomedin 4 deletion induces colon adenocarcinoma in ApcMin/+ mice. Oncogene. doi:10.1038/onc.2016.58.

    Google Scholar 

  29. VanDussen, K. L., Carulli, A. J., Keeley, T. M., Patel, S. R., Puthoff, B. J., Magness, S. T., et al. (2012). Notch signaling modulates proliferation and differentiation of intestinal crypt base columnar stem cells. Development, 139(3), 488–497.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Block, A. S., Saraswati, S., Lichti, C. F., Mahadevan, M., & Diekman, A. B. (2011). Co-purification of Mac-2 binding protein with galectin-3 and association with prostasomes in human semen. Prostate, 71(7), 711–721.

    Article  CAS  PubMed  Google Scholar 

  31. Li, H., Liu, W., Chen, W., Zhu, J., Deng, C. X., & Rodgers, G. P. (2015). Olfactomedin 4 deficiency promotes prostate neoplastic progression and is associated with upregulation of the hedgehog-signaling pathway. Scientific Reports, 5, 16974. doi:10.1038/srep16974.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Welin, A., Amirbeagi, F., Christenson, K., Bjorkman, L., Bjornsdottir, H., Forsman, H., et al. (2013). The human neutrophil subsets defined by the presence or absence of OLFM4 both transmigrate into tissue in vivo and give rise to distinct NETs in vitro. PloS One, 8(7), e69575.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Amirbeagi, F., Thulin, P., Pullerits, R., Pedersen, B., Andersson, B. A., Dahlgren, C., et al. (2015). Olfactomedin-4 autoantibodies give unusual c-ANCA staining patterns with reactivity to a subpopulation of neutrophils. Journal of Leukocyte Biology, 97(1), 181–189.

    Article  PubMed  Google Scholar 

  34. Shinozaki, S., Nakamura, T., Iimura, M., Kato, Y., Iizuka, B., Kobayashi, M., et al. (2001). Upregulation of Reg 1alpha and GW112 in the epithelium of inflamed colonic mucosa. Gut, 48(5), 623–629.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Gersemann, M., Becker, S., Nuding, S., Antoni, L., Ott, G., Fritz, P., et al. (2012). Olfactomedin-4 is a glycoprotein secreted into mucus in active IBD. Journal of Crohn's & Colitis, 6(4), 425–434.

    Article  Google Scholar 

  36. Mannick, E. E., Schurr, J. R., Zapata, A., Lentz, J. J., Gastanaduy, M., Cote, R. L., et al. (2004). Gene expression in gastric biopsies from patients infected with Helicobacter pylori. Scandinavian Journal of Gastroenterology, 39(12), 1192–1200.

    Article  CAS  PubMed  Google Scholar 

  37. van der Flier, L. G., Haegebarth, A., Stange, D. E., van de Wetering, M., & Clevers, H. (2009). OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells. Gastroenterology, 137(1), 15–17.

    Article  PubMed  Google Scholar 

  38. Ziskin, J. L., Dunlap, D., Yaylaoglu, M., Fodor, I. K., Forrest, W. F., Patel, R., et al. (2013). In situ validation of an intestinal stem cell signature in colorectal cancer. Gut, 62(7), 1012–1023.

    Article  CAS  PubMed  Google Scholar 

  39. Schuijers, J., van der Flier, L. G., van Es, J., & Clevers, H. (2014). Robust cre-mediated recombination in small intestinal stem cells utilizing the olfm4 locus. Stem Cell Reports, 3(2), 234–241.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Besson, D., Pavageau, A. H., Valo, I., Bourreau, A., Belanger, A., Eymerit-Morin, C., et al. (2011). A quantitative proteomic approach of the different stages of colorectal cancer establishes OLFM4 as a new nonmetastatic tumor marker. Molecular & Cellular Proteomics, 10(12), M111 009712.

  41. Seko, N., Oue, N., Noguchi, T., Sentani, K., Sakamoto, N., Hinoi, T., et al. (2010). Olfactomedin 4 (GW112, hGC-1) is an independent prognostic marker for survival in patients with colorectal cancer. Experimental Theoretical Medicine, 1(1), 73–78.

    Google Scholar 

  42. Comprehensive molecular characterization of human colon and rectal cancer (2012). Nature, 487(7407), 330–337.

  43. Jang, B. G., Lee, B. L., & Kim, W. H. (2015). Olfactomedin-related proteins 4 (OLFM4) expression is involved in early gastric carcinogenesis and of prognostic significance in advanced gastric cancer. Virchows Archiv. doi:10.1007/s00428-015-1793-9.

    Google Scholar 

  44. Lee, H. J., Nam, K. T., Park, H. S., Kim, M. A., Lafleur, B. J., Aburatani, H., et al. (2010). Gene expression profiling of metaplastic lineages identifies CDH17 as a prognostic marker in early stage gastric cancer. Gastroenterology, 139(1), 213–225 e213.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Oue, N., Sentani, K., Noguchi, T., Ohara, S., Sakamoto, N., Hayashi, T., et al. (2009). Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients. International Journal of Cancer, 125(10), 2383–2392.

    Article  CAS  PubMed  Google Scholar 

  46. Luo, Z., Zhang, Q., Zhao, Z., Li, B., Chen, J., & Wang, Y. (2011). OLFM4 is associated with lymph node metastasis and poor prognosis in patients with gastric cancer. Journal of Cancer Research and Clinical Oncology, 137(11), 1713–1720.

    Article  CAS  PubMed  Google Scholar 

  47. Liu, R. H., Yang, M. H., Xiang, H., Bao, L. M., Yang, H. A., Yue, L. W., et al. (2012). Depletion of OLFM4 gene inhibits cell growth and increases sensitization to hydrogen peroxide and tumor necrosis factor-alpha induced-apoptosis in gastric cancer cells. Journal of Biomedical Science, 19, 38. doi:10.1186/1423-0127-19-38.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Li, H., Rodriguez-Canales, J., Liu, W., Zhu, J., Hanson, J. C., Pack, S., et al. (2013). Deletion of the olfactomedin 4 gene is associated with progression of human prostate cancer. The American Journal of Pathology, 183(4), 1329–1338.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Kobayashi, D., Koshida, S., Moriai, R., Tsuji, N., & Watanabe, N. (2007). Olfactomedin 4 promotes S-phase transition in proliferation of pancreatic cancer cells. Cancer Science, 98(3), 334–340.

    Article  CAS  PubMed  Google Scholar 

  50. Makawita, S., Smith, C., Batruch, I., Zheng, Y., Ruckert, F., Grutzmann, R., et al. (2011). Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers. Mol Cell Proteomics, 10(10), M111 008599.

  51. Yan, H., Lu, D., Xu, L., Xie, Q., Dong, X., & Wu, Y. (2011). Increased expression level of Olfactomedin4 in peripheral blood mononuclear cells of pancreatic adenocarcinoma patients. Hepato-Gastroenterology, 58(109), 1354–1359.

    CAS  PubMed  Google Scholar 

  52. Cuoghi, A., Farina, A., Z'Graggen, K., Dumonceau, J. M., Tomasi, A., Hochstrasser, D. F., et al. (2011). Role of proteomics to differentiate between benign and potentially malignant pancreatic cysts. Journal of Proteome Research, 10(5), 2664–2670.

    Article  CAS  PubMed  Google Scholar 

  53. Takadate, T., Onogawa, T., Fukuda, T., Motoi, F., Suzuki, T., Fujii, K., et al. (2013). Novel prognostic protein markers of resectable pancreatic cancer identified by coupled shotgun and targeted proteomics using formalin-fixed paraffin-embedded tissues. International Journal of Cancer, 132(6), 1368–1382.

    Article  CAS  PubMed  Google Scholar 

  54. Suknuntha, K., Ishii, Y., Tao, L., Hu, K., McIntosh, B. E., Yang, D., et al. (2015). Discovery of survival factor for primitive chronic myeloid leukemia cells using induced pluripotent stem cells. Stem Cell Research, 15(3), 678–693.

    Article  CAS  PubMed  Google Scholar 

  55. Duan, C., Liu, X., Liang, S., Yang, Z., Xia, M., Wang, L., et al. (2014). Oestrogen receptor-mediated expression of Olfactomedin 4 regulates the progression of endometrial adenocarcinoma. Journal of Cellular and Molecular Medicine, 18(5), 863–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Marimuthu, A., Chavan, S., Sathe, G., Sahasrabuddhe, N. A., Srikanth, S. M., Renuse, S., et al. (2013). Identification of head and neck squamous cell carcinoma biomarker candidates through proteomic analysis of cancer cell secretome. Biochimica et Biophysica Acta, 1834(11), 2308–2316.

    Article  CAS  PubMed  Google Scholar 

  57. Koshida, S., Kobayashi, D., Moriai, R., Tsuji, N., & Watanabe, N. (2007). Specific overexpression of OLFM4(GW112/HGC-1) mRNA in colon, breast and lung cancer tissues detected using quantitative analysis. Cancer Science, 98(3), 315–320.

    Article  CAS  PubMed  Google Scholar 

  58. Su, W., Luo, L., Wu, F., Lai, Z., Li, X., Xie, Z., et al. (2015). Low expression of olfactomedin 4 correlates with poor prognosis in smoking patients with non-small cell lung cancer. Human Pathology, 46(5), 732–8.

    Article  CAS  PubMed  Google Scholar 

  59. Bradfield, J. P., Taal, H. R., Timpson, N. J., Scherag, A., Lecoeur, C., Warrington, N. M., et al. (2012). A genome-wide association meta-analysis identifies new childhood obesity loci. Nature Genetics, 44(5), 526–531.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

We thank Dr. Weiping Chen, Genomic Core Laboratory, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, for assistance with database analysis.

Author information

Authors and Affiliations

  1. Molecular and Clinical Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bldg. 10, Room 9N119, 9000 Rockville Pike, Bethesda, MD, 20892, USA

    Wenli Liu & Griffin P. Rodgers

Authors
  1. Wenli Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Griffin P. Rodgers
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Griffin P. Rodgers.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(PDF 52 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, W., Rodgers, G.P. Olfactomedin 4 expression and functions in innate immunity, inflammation, and cancer. Cancer Metastasis Rev 35, 201–212 (2016). https://doi.org/10.1007/s10555-016-9624-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10555-016-9624-2

Keywords

Search

Navigation